#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypergammaglobulinaemia benign monoclonal Diabetes insipidus Antiphospholipid antibodies Oropharyngeal cancer recurrent Infantile spasms Diffuse large B-cell lymphoma Pustular psoriasis Soft tissue sarcoma Alternating hemiplegia of childhood Isodicentric chromosome 15 syndrome B-cell small lymphocytic lymphoma refractory Small intestine leiomyosarcoma Rheumatoid arthritis Oropharyngeal squamous cell carcinoma Pemphigus More trials…

    Learn about Rare Diseases

    Sarcoidosis Ewing’s sarcoma metastatic – Life with Disease Glomerulonephritis membranous – Life with Disease Pleural mesothelioma malignant – Treatment Rhabdoid tumour – Life with Disease KBG syndrome – Trials in Disease MELAS syndrome – Trials in Disease Mantle cell lymphoma stage III – Trials in Disease Progressive supranuclear palsy – Trials in Disease Hereditary motor and sensory neuropathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PEGVISOMANT Obefazimod Rizolipase SAR443820 CARBOMER 980 Anhydrous Cidofovir Mk-2060 ATUMELNANT Ixekizumab Adg126 Tolcapone Efmoroctocog Alfa GS-248 Eftrenonacog Alfa Amikacin Phenobarbital Poractant Alfa Cemiplimab Ferrous Sulfate VGA039 More therapies…

    Learn about Your Condition

    COVID-19 Plasma cell myeloma recurrent Oral neoplasm Endocarditis Osteoporosis postmenopausal Breast cancer stage I Skin ulcer Large cell lung cancer stage 0 Craniotomy Lipid metabolism disorder Mucopolysaccharidosis II Meniere's disease Bone marrow disorder Immunosuppression Oesophageal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on Human Plasma Protein vs. Crystalloid for Fluid Management in Children with Scoliosis Undergoing Spinal Fusion Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuromuscular scoliosis
    Investigated Drugs:
    • Human Plasma Protein
    • Magnesium Chloride Hexahydrate
    • Sodium Acetate Trihydrate
    Finland

  • Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Zoledronic Acid
    France

  • Study of psilocybin therapy for psychological distress in patients with COPD, ALS, multiple sclerosis, or atypical Parkinson’s disorders

    Recruiting

    2 1 1
    Investigated Drugs:
    • Psilocybine
    Czechia Denmark The Netherlands Portugal

  • A study of tranexamic acid to reduce blood loss during hip surgery in children with hip dysplasia and other hip conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    • Saline
    The Netherlands

  • Study on Reducing Treatment Frequency of Alglucosidase Alfa for Elderly Patients with Late-Onset Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Alglucosidase Alfa
    • Avalglucosidase Alfa
    • Cipaglucosidase Alfa
    The Netherlands

  • Study on Fecal Microbiota Transplantation for Patients with Axial Spondyloarthritis Resistant to Conventional Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France
Previous Page
1 … 17 18 19 20 21 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!